LOUISVILLE, KY (WAVE) - The University of Louisville is leading the fighting in treating advanced Melanoma.
The James Graham Brown Cancer Center is the first site in Kentucky to provide a newly FDA approved treatment called Keytruda.
The treatment is for patients with advanced or inoperable melanoma who are no longer responding to other drugs.
Melanoma accounts for five percent of all cancers in the United States.
Jason Chesney, with the James Graham Brown Cancer Center, said, "The drug will activate your immune system against the cancer. And what's really exciting about that is it works for a lot of different types of cancer."
Keytruda was given accelerated approval by the FDA Sept. 4.